Beryl Drugs Ltd Faces Intense Selling Pressure Amid Significant Price Declines
Beryl Drugs Ltd is experiencing significant selling pressure, marked by consecutive losses and a notable decline over various time frames. The stock is trading near its 52-week low and underperforming its sector, indicating a challenging environment that has led to ongoing negative sentiment among investors.
Beryl Drugs Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 4.95% in just one day, starkly contrasting with the Sensex's minor drop of 0.32%. Over the past week, Beryl Drugs has lost 10.04%, while the Sensex has gained 0.32%. The stock's performance over the past month reveals a steep decline of 18.42%, compared to the Sensex's increase of 6.87%. This trend continues over longer periods, with Beryl Drugs down 42.53% over the last three months and 47.22% year-to-date, while the Sensex has shown positive returns of 3.18% and 3.08%, respectively.
Currently, Beryl Drugs is trading close to its 52-week low, just 2.21% away from Rs 18.58. The stock is also underperforming its sector by 4.21% and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. These factors suggest a challenging environment for Beryl Drugs, contributing to the ongoing selling pressure.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
